Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 7.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.10
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 193.63m
  • Volume: 98,149
  • Market Cap: £15.01m
  • Beta: 0.43

Abingdon Health surges after launch of Covid-19 antibody self-test

By Michele Maatouk

Date: Monday 23 Aug 2021

LONDON (ShareCast) - (Sharecast News) - Abingdon Health surged on Monday after launching a Covid-19 antibody self-test it manufactured with BioSure.
The new test, for which BioSure is the legal manufacturer, has been CE marked specifically for self-testing. It uses a fraction of a drop of finger-prick blood and gives results in 20 minutes.

This allows individuals to know and monitor their own antibody status pre-vaccination, post vaccination and following infection with the SARS-CoV-2 virus. Abingdon said it will be particularly useful as populations worldwide continue to be vaccinated to monitor the effectiveness of an individual's immunity status.

Chief executive officer Chris Yates said: "We are delighted that BioSure have launched their product and equally happy to be their manufacturing partner. For individuals to be able to monitor their own antibody status at home is a great step in the management of Covid-19.

"Our own AbC-19 assay will complement this product and we expect the AbC-19 to gain additional utility in semi-quantitative format as recently announced. BioSure also distributes our AbC-19 test which is CE marked for professional use."

At 1400 BST, Abingdon shares were up 58% at 46p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 7.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.10
52 Week Low 6.75
Volume 98,149
Shares Issued 193.63m
Market Cap £15.01m
Beta 0.43

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.3% below the market average49.3% below the market average49.3% below the market average49.3% below the market average49.3% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average
Price Trend
5.36% below the market average5.36% below the market average5.36% below the market average5.36% below the market average5.36% below the market average
13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average
Income Not Available
Growth
28.01% above the market average28.01% above the market average28.01% above the market average28.01% above the market average28.01% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

ABDX Dividends

No dividends found

Trades for 24-Dec-2024

Time Volume / Share Price
11:51 10,000 @ 7.74p
11:00 17,500 @ 7.51p
10:38 5,815 @ 7.75p
10:21 6,795 @ 7.51p
08:53 25,680 @ 7.77p

ABDX Key Personnel

CEO Chris Henry Francis Yates

Top of Page